| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |